Walgreens to Start Selling its Own OTC Naloxone Nasal Spray
Drug Topics
MAY 15, 2024
The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.
Wed.May 15, 2024
525 
My rendezvous with the raw milk black market: quick, easy, and unchecked by the FDA
STAT
MAY 15, 2024
WASHINGTON — It’s Friday May 10, and I’m on my way to what feels like the world’s weirdest drug deal. I received a text the day before from a man named Karl. My order would be arriving from Maryland between 2 and 4 p.m. at the northwest D.C. drop site. It’ll be safely wrapped in ice packs, he assured me.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Reviewing Efficacy, Safety of Weight Loss Therapies in T1D
Drug Topics
MAY 15, 2024
Different weight loss therapies provide a wide range of benefits to patients with T1D—but they have some potential adverse effects.
Collaboration Is Key When Implementing SDOH Screening Programs
Pharmacy Times
MAY 15, 2024
Properly training staff and gaining stakeholder buy-in are crucial steps to successfully designing and launching a program to screen and address health-related social needs.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Flawless Fallacy: A Pharmacist’s Guide to Skin Care in the Digital Age
Drug Topics
MAY 15, 2024
Cutting through the noise of social media is key when educating patients on how to make better choices for their skin.
FDA Ensures Safety and Effectiveness of Laboratory Developed Tests
Pharmacy Times
MAY 15, 2024
Under the modification to the Food, Drug, & Cosmetics Act, individuals and health care providers can hopefully have more confidence in in vitro diagnostic devices.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Drug overdose deaths fell for first time in five years, though still exceeded 100,000
STAT
MAY 15, 2024
U.S. drug deaths decreased slightly in 2023, according to new data, the first decrease in five years. Last year saw 107,543 U.S. drug overdose deaths, according to preliminary statistics released Wednesday by the Centers for Disease Control and Prevention, roughly a 3% drop from 2022.
T1D Prevalence Increased Among US Adults Aged 45 to 64
Drug Topics
MAY 15, 2024
Type 1 diabetes (T1D), which once predominantly affected children, is increasingly affecting older adults in the US, with prevalence rates peaking in those aged 45 to 64, according to recent research.
Study: Contact With Children Causes Transmission of Pneumococcal Disease Among Older Adults
Pharmacy Times
MAY 15, 2024
The prevalence of transmission was higher for those who had contact with children aged less than 5 years and aged 5 to 9 years compared with children aged older than 10.
Uber Health to roll out new caregiving solution to simplify benefits, logistics for families
Fierce Healthcare
MAY 15, 2024
NEW YORK CITY—Uber Health will begin rolling out a new solution designed for caregivers this summer, the company announced at its annual product event Wednesday. | Uber Caregiver will allow care-receivers to add a caregiver to their Uber profile so they can see and spend their health benefits on eligible services, request rides to doctor’s appointments or order groceries.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Expansion of OTC Medications: What Does This Mean for Pharmacy?
Pharmacy Times
MAY 15, 2024
Student pharmacists are uniquely positioned to support community pharmacists and help educate members of their community and other health care professionals.
Senators Whitehouse, Cassidy propose bipartisan primary care payment reform, seek industry feedback
Fierce Healthcare
MAY 15, 2024
U.S. | Senators Sheldon Whitehouse and Bill Cassidy want to reform how primary care providers get paid through Medicare, and they also want to hear from the healthcare industry about the best way to do it.
Continued Tezepelumab Treatment Benefits Patients With Severe, Uncontrolled Asthma
Pharmacy Times
MAY 15, 2024
The continuation of tezepelumab showed stronger benefits after stopping treatment for 2 years and compared with placebo.
As Lilly surges, headwinds against its weight loss drugs are growing
PharmaVoice
MAY 15, 2024
After missing analysts’ earnings expectations for Mounjaro sales in the first quarter due to overwhelming demand, Lilly is also dealing with a legal loss and incoming pricing questions from lawmakers.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
To detect risk of stroke, tiny probe acts ‘like a microscope’ inside brain’s blood vessels
STAT
MAY 15, 2024
To better understand problems in the brain’s blood vessels that may lead to stroke, we need a better way to see them. Cardiovascular imaging can peer inside coronary arteries to spot clots blocking blood flow to the heart, but those tools are dangerously large for the smaller arteries inside the brain that twist and turn in tortuous ways. Now researchers have designed a probe minuscule enough to fit inside the microcatheters that surgeons snake into cerebral arteries to place reinforcing
House Energy and Commerce Committee presents own 2-year telehealth extension, with more rural health wins
Fierce Healthcare
MAY 15, 2024
The Energy and Commerce Committee released telehealth extension legislation today that will be voted on during a health subcommittee markup Thursday. | The House Energy and Commerce health subcommittee will hold a markup May 16 that includes a different two-year telehealth extension proposal than the Ways and Means Committee passed last week.
Opinion: Listen: Free medical tuition alone isn’t enough to close gaps in primary care
STAT
MAY 15, 2024
In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics.
GSK, UK govt put £130m into antimicrobial resistance fight
pharmaphorum
MAY 15, 2024
GSK has become the first founding partner of the new Fleming Initiative, which aims to tackle the rising threat of antimicrobial resistance (AMR) and is also backed by the UK government.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Opinion: Cutting-edge insulin is good. But it’s the ‘trailing edge’ of older versions that can keep it affordable
STAT
MAY 15, 2024
Physicians Frederick Banting and John MacLeod declined to be listed on the patent for insulin in 1923; their co-inventors Charles Best and James Collip sold the patent to the University of Toronto for $1. But despite the discoverers’ efforts to make insulin available and cheap for everyone, it has today become the poster child for soaring pharmaceutical prices.
Home testing devices for sleep apnoea backed for NHS use
pharmaphorum
MAY 15, 2024
Five home-testing devices to diagnose sleep apnoea, which can affect the health of around 2.5 million adults in the UK, have been recommended for NHS use by NICE.
STAT+: Galapagos, in makeover mode, strikes deal to make CAR-T therapies at blood centers across U.S.
STAT
MAY 15, 2024
Seeking to differentiate itself from other makers of CAR-T cancer therapies, Galapagos NV on Wednesday announced it had struck a deal with Blood Centers of America to open up dozens of manufacturing sites for its cell-based medicines around the U.S. Galapagos said it will rely on the partnership, the financial terms of which were not disclosed, as it moves its CAR-Ts for different cancers into pivotal studies and could also help launch those medicines should they win approval.
Workforce training, emergency response funding top AHA's FY2025 appropriations asks
Fierce Healthcare
MAY 15, 2024
As Congress hammers out the federal budget for 2025, the hospital industry’s wish list is headlined by programs to strengthen the healthcare workforce and hospitals’ emergency response capabilities | The hospital lobby called for "bold increases" in Health Resources and Services Administration discretionary funding to address "the workforce crisis facing our nation" in letters this week to congressional appropriations subcommittees.
STAT+: Pharmalittle: We’re reading about fake studies, AbbVie investing in psychedelics, and more
STAT
MAY 15, 2024
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the sobering possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is maple bourbon.
Case Study: MHRA
pharmaphorum
MAY 15, 2024
MHRA's innovative regulatory approach enables Nuwiq's accelerated clinical trial timeline for haemophilia patients. Learn how their flexible approach is speeding access to new treatments.
STAT+: Abbott’s dissolvable stent, which failed in heart disease patients, may help vascular patients
STAT
MAY 15, 2024
An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease. The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.
FDA clears BMS’ Breyanzi for follicular lymphoma
pharmaphorum
MAY 15, 2024
BMS gets another FDA approval for its CD19-directed CAR-T Breyanzi, this time as a third-line or later therapy for follicular lymphoma
Leqembi gets closer to being offered as an injection
STAT
MAY 15, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of my colleagues are traveling to San Francisco (without me) for our Breakthrough West Summit happening tomorrow. If you have FOMO like me, you can still register to get a virtual pass.
FDA clears Roche self-collection system for HPV screening
pharmaphorum
MAY 15, 2024
The FDA has approved Roche's HPV self-sampling solution that the company says can tackle unequal access to screening that can put women at risk of cervical cancer
STAT+: WuXi Biologics execs register to lobby as Congress comes for the company
STAT
MAY 15, 2024
WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States. Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee.
Updated BIOSECURE Act draft clears House committee
pharmaphorum
MAY 15, 2024
House Oversight Committee passes BIOSECURE Act, which would restrict US companies from contracting with Chinese biotechs including WuXi AppTec, MGI and BGI
LogiPharma Europe 2024: World Courier President Talks Mitigating Supply Chain Risks
Pharmaceutical Commerce
MAY 15, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno at LogiPharma Europe, Nick Porter, President, World Courier discusses mitigating supply chain risks, the future of artificial intelligence in pharma logistics, and more.
AbbVie takes option on Gilgamesh psychedelics in $2bn deal
pharmaphorum
MAY 15, 2024
AbbVie joins a select group of big pharma groups working on psychedelic medicines, paying $65m on an option deal with Gilgamesh Pharma
FDA approves Roche’s HPV self-collection screening option
Pharmafile
MAY 15, 2024
Roche has announced that the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-collection solution. This makes the solution one of the first available in the US, allowing more women to utilise an accessible screening option. The post FDA approves Roche’s HPV self-collection screening option appeared first on Pharmafile.
Let's personalize your content